Sotorasib in KRASG12C mutated lung cancer

被引：0
|
作者：
Olivier, Timothee [1 ]
Prasad, Vinay [2 ]
机构：
[1] Geneva Univ Hosp, Dept Oncol, CH-1205 Geneva, Switzerland
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
来源：
LANCET | 2024年 / 403卷 / 10422期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor
    Zhang, Liang
    Griffin, Daniel J.
    Beaver, Matthew G.
    Blue, Laura E.
    Borths, Christopher J.
    Brown, Derek B.
    Caille, Seb
    Chen, Ying
    Cherney, Alan H.
    Cochran, Brian M.
    Colyer, John T.
    Corbett, Michael T.
    Correll, Tiffany L.
    Crockett, Richard D.
    Dai, Xi-Jie
    Dornan, Peter K.
    Farrell, Robert P.
    Hedley, Simon J.
    Hsieh, Hsiao-Wu
    Huang, Liang
    Huggins, Seth
    Liu, Min
    Lovette, Michael A.
    Quasdorf, Kyle
    Powazinik, William
    Reifman, Jonathan
    Robinson, Jo Anna
    Sangodkar, Rahul P.
    Sharma, Sonika
    Kumar, Srividya Sharvan
    Smith, Austin G.
    St-Pierre, Gabrielle
    Tedrow, Jason S.
    Thiel, Oliver R.
    Truong, Jonathan V.
    Walker, Shawn D.
    Wei, Carolyn S.
    Wilsily, Ashraf
    Xie, Yong
    Yang, Ning
    Parsons, Andrew T.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (11) : 3115 - 3125
  • [22] A Novel Inhibitor for KRASG12C Mutant Lung Carcinoma
    Khan, H. Y.
    Li, Y.
    Aboukameel, A.
    Mpilla, G.
    Sexton, R.
    Kanbur, T.
    Cetinkaya, H.
    Cagir, A.
    Al-Hallak, M. N.
    Sukari, A.
    Azmi, A. S.
    Nagasaka, M.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S15 - S15
  • [23] Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC)
    Kim, Eejung
    Tong, Xinyuan
    Patel, Ayushi
    Liu, Shengwu
    Dilly, Julien
    Hover, Laura
    Mukhopadhyay, Suman
    Sherman, Fiona
    Christensen, James G.
    Olson, Peter
    Aguirre, Andrew
    Wong, Kwok
    Ji, Hongbin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Acquired Resistance to KRASG12C Inhibition in Cancer
    Awad, M. M.
    Liu, S.
    Rybkin, I. I.
    Arbour, K. C.
    Dilly, J.
    Zhu, V. W.
    Johnson, M. L.
    Heist, R. S.
    Patil, T.
    Riely, G. J.
    Jacobson, J. O.
    Yang, X.
    Persky, N. S.
    Root, D. E.
    Lowder, K. E.
    Feng, H.
    Zhang, S. S.
    Haigis, K. M.
    Hung, Y. P.
    Sholl, L. M.
    Wolpin, B. M.
    Wiese, J.
    Christiansen, J.
    Lee, J.
    Schrock, A. B.
    Lim, L. P.
    Garg, K.
    Li, M.
    Engstrom, L. D.
    Waters, L.
    Lawson, J. D.
    Olson, P.
    Lito, P.
    Ou, S. -H. I.
    Christensen, J. G.
    Janne, P. A.
    Aguirre, A. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) : 2382 - 2393
  • [25] Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Cardona, Andres Felipe
    Recondo, Gonzalo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] KRASG12C inhibition enhances immunogenicity in KRASG12C-mutant colorectal cancer
    Patel, Parasvi S.
    Tian, Jun
    de la Cruz, Ferran Fece
    Curtis, Jacquelyn
    Panda, Apekshya
    Oka, Tomonori
    Demehri, Shadmehr
    Sade-Feldman, Moshe
    Koptez, Scott
    Corcoran, Ryan B.
    CANCER RESEARCH, 2024, 84 (07)
  • [27] KRASG12C inhibitors on the horizon
    Cagir, Ali
    Azmi, Asfar S.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 923 - 925
  • [28] Sotorasib-induced liver and non-liver toxicity associated with sequential sotorasib following anti-PD(L)1 in KRASG12C mutant lung cancer
    Chour, A.
    Denis, J.
    Lafitte, C.
    Mascaux, C.
    Zysman, M.
    Lemaitre, A.
    Swalduz, A.
    Gounant, V.
    Cortot, A.
    Darrason, M.
    Cadranel, J.
    Auclin, E.
    Basse, C.
    Tissot, C.
    Decroisette, C.
    Bombaron, P.
    Giroux-Leprieur, E.
    Falchero, L.
    Lebosse, F.
    Duruisseaux, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S49 - S50
  • [29] Bcl-xL and association with apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer.
    Khawaja, Hajrah
    Briggs, Rebecca
    Latimer, Cheryl
    Rassel, Md A. M. B.
    Griffin, Daryl
    Hanson, Lyndsey
    Bardelli, Alberto
    Di Nicolantonio, Federica
    McDade, Simon
    Scott, Christopher
    Lambe, Shauna
    Maurya, Manisha
    Lindner, Andreas Ulrich
    Prehn, Jochen H. M.
    Sousa, Jose
    Winnington, Chris
    LaBonte, Melissa J.
    Ross, Sarah
    Van Schaeybroeck, Sandra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] KRASG12C exhibits allele-specific biology in pancreatic cancer and targeting CD24 sensitizes KRASG12C-driven tumors to sotorasib treatment
    Wei, Yongkun
    Liu, Minghui
    Nguyen, Phuoc T.
    Pan, Dean N.
    Yao, Wantong
    Ying, Haoqiang
    CANCER RESEARCH, 2024, 84 (02)
12345